ORSO, Francesca
 Distribuzione geografica
Continente #
EU - Europa 5.289
NA - Nord America 2.033
AS - Asia 1.384
SA - Sud America 161
AF - Africa 121
Continente sconosciuto - Info sul continente non disponibili 69
OC - Oceania 1
Totale 9.058
Nazione #
NL - Olanda 3.752
US - Stati Uniti d'America 1.940
RU - Federazione Russa 572
SG - Singapore 531
IE - Irlanda 280
CN - Cina 260
IT - Italia 226
HK - Hong Kong 203
VN - Vietnam 163
DE - Germania 158
BR - Brasile 116
BJ - Benin 92
FR - Francia 83
KR - Corea 55
GB - Regno Unito 54
CA - Canada 43
BD - Bangladesh 42
ID - Indonesia 41
SE - Svezia 37
FI - Finlandia 25
IN - India 23
MX - Messico 21
AT - Austria 19
PL - Polonia 18
UA - Ucraina 18
JP - Giappone 15
AR - Argentina 14
ES - Italia 12
IQ - Iraq 11
LT - Lituania 9
BE - Belgio 7
CL - Cile 7
EC - Ecuador 7
NI - Nicaragua 7
TR - Turchia 7
ZA - Sudafrica 7
EG - Egitto 6
PH - Filippine 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
CH - Svizzera 4
DK - Danimarca 4
JM - Giamaica 4
MA - Marocco 4
UY - Uruguay 4
AL - Albania 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KE - Kenya 3
NP - Nepal 3
PR - Porto Rico 3
PY - Paraguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
BO - Bolivia 2
CO - Colombia 2
EE - Estonia 2
HN - Honduras 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BH - Bahrain 1
ET - Etiopia 1
GY - Guiana 1
IL - Israele 1
JO - Giordania 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PW - Palau 1
SN - Senegal 1
SV - El Salvador 1
TC - Turks e Caicos 1
TG - Togo 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 8.989
Città #
Amsterdam 3.745
San Jose 303
Council Bluffs 299
Dublin 279
Hong Kong 202
Singapore 189
Ashburn 153
Beijing 114
Columbus 92
Cotonou 92
Los Angeles 75
Moscow 64
Lauterbourg 56
Seoul 54
Mülheim 49
Santa Clara 49
Ho Chi Minh City 48
Buffalo 43
New York 38
Phoenix 36
Jakarta 35
Hanoi 28
Schaumburg 27
Turin 26
Dallas 24
Falkenstein 22
Helsinki 21
Brooklyn 19
Jacksonville 19
Novara 18
Warsaw 18
Dong Ket 16
Atlanta 15
Milan 15
Montreal 15
Nuremberg 14
Olathe 14
Tokyo 14
Mexico City 13
Denver 12
São Paulo 12
Bremen 11
Chennai 11
Frankfurt am Main 11
Munich 11
Orem 11
Vercelli 11
Dearborn 10
North Bergen 10
Rome 10
Chicago 9
Da Nang 9
London 9
St Louis 9
Tianjin 9
Boardman 8
Piemonte 8
Houston 7
San Francisco 7
Assago 6
Baghdad 6
Boston 6
Brussels 6
Haiphong 6
Managua 6
Naples 6
Stockholm 6
Toronto 6
Guangzhou 5
Lawrence 5
Vienna 5
Wilmington 5
Grants Pass 4
Guayaquil 4
Hillsboro 4
Kansas City 4
Montevideo 4
Philadelphia 4
Poplar 4
Princeton 4
Queens 4
Ankara 3
Bauru 3
Belo Horizonte 3
Brasília 3
Bắc Ninh 3
Cairo 3
Charlotte 3
Dayton 3
Florence 3
Goiânia 3
Guarujá 3
Hangzhou 3
Istanbul 3
Johannesburg 3
Manchester 3
Miami 3
Milwaukee 3
Ottawa 3
Ribeirão Preto 3
Totale 6.715
Nome #
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.993
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.990
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 144
Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes 123
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 118
Mir-214 and mir-148b targeting inhibits dissemination of melanoma and breast cancer 105
Stroma-derived miR-214 coordinates tumor dissemination 104
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 102
TCR gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naïve and memory T-cells without prior stimulation of endogenous TCR 98
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3 95
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 92
Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion 92
Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma 91
MicroRNAs in metabolism for precision treatment of lung cancer 87
Emerging roles of 3D-culture systems in tackling tumor drug resistance 85
The chimeric aptamer axl-miR-214sponge inhibits breast cancer and melanoma dissemination 85
AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC 83
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia 83
miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions 83
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 82
A computational pipeline to identify new potential regulatory motifs in melanoma progression. 82
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells 82
Do predicted microRNAs control gene networks involved in breast cancer progression? 82
Analysis of the regulatory regions of AP-2alpha-modulated genes selected for oral presentation and winner of the "Premio Chiara D'Onofrio Giovani Riercatori 2009" 80
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation 80
The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies 79
The role of melatonin on miRNAs modulation in triple-negative breast cancer cells 78
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 77
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia 76
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 76
AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase 76
Interference with Activator Protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation- sensitivity in breast cancer cells 75
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS and CSF1 75
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 75
microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 74
3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner 74
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment 74
Formation of STAT5/PPAR{gamma} Transcriptional Complex Modulates Angiogenic Cell Bioavailability in Diabetes 74
DIFFERENTIAL REGULATION OF AP-2 GENES BY ESTROGEN IN HUMAN BREAST CANCER CELLS 73
Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region 73
MiR-146a exerts differential effects on melanoma growth and metastatization 73
Role of coactivators and corepressors in steroid and nuclear receptor signaling: potential markers of tumor growth and drug sensitivity 72
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition 70
DIFFERENTIAL REGULATION OF AP-2 TRANSCRIPTION FACTOR GENE EXPRESSION BY ESTROGEN IN HUMAN BREAST CANCER CELLS 70
ACTIVATOR PROTEIN-2 ALPHA TRANSCRIPTION FACTOR ROLES IN NEURONS 70
microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression 70
The Ap-Alpha transcription factor regulates tumor cell migration 69
miR-148b is a major coordinator in a Relapse-associated miR signature in Breast Tumors 68
miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation 67
CyTRANSFINDER: A Cytoscape 3.3 plugin for three-component (TF, gene, miRNA) signal transduction pathway construction 67
microRNA and cancer progression in Breast Tumours 67
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 66
miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions 66
Role of miRNAs in tumor and endothelial cell interactions during tumor progression 66
High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma 64
Investigating the epi-miRNome: Identification of epi-miRNAs using transfection experiments 64
miR-21 coordinates tumor growth and modulates KRIT1 levels 64
Do predicted microRNAs control gene networks involved in breast cancer progression? 61
Co-localization of AP2alpha transcription factor and TH-immunoreactive neurons in mouse locus coeruleus 60
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 59
POSSIBLE OESTROGENIC EFFECTS ON AP-2 ALPHA EXPRESSION AND AP-2 ALPHA POTENTIAL ROLE IN nNOS REGULATION IN MOUSE HYPOTHALAMUS 57
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells 56
Identification of new AP-2alpha regulated genes: a biological and bioinformatic approach 51
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 51
Identification and characterization of microRNAs involved in tumor progression and metastasis 49
The AP-2alpha and AP-2gamma transcription factors regulate tumor formation 44
The AP-2alpha and AP-2gamma transcription factors regulate tumor progression and cell movement via specific genetic programs 43
Mitochondrial IκBα fuels cancer progression through metabolic rewiring, endothelial activation, and thrombotic spread 33
Transcriptome changes in circulating immune cells of critical COVID-19 patients predict a specific metabolic and epigenetic imprint 25
The promising regenerative potential of pulsed electromagnetic fields toward tendon differentiation 23
null 23
Totale 9.058
Categoria #
all - tutte 34.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 0 0 4 1 0 2 0 3 1 1 6
2022/2023426 6 2 2 1 11 24 3 31 249 36 58 3
2023/2024284 17 18 40 17 61 3 42 7 3 2 25 49
2024/2025943 18 3 131 6 31 31 122 67 222 98 46 168
2025/20266.400 123 132 177 275 327 233 339 404 3.881 286 139 84
2026/2027887 122 217 174 374 0 0 0 0 0 0 0 0
Totale 9.058